Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.89 billion
P/E Ratio 273.86
Dividend Yield 0.82%
Shares Outstanding 1.63 billion
Earnings per share 0.004
Dividend per share 0.01
Year To Date Return 20.40%
Earnings Yield 0.37%
Franking 50
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
    Share Fallers

    Why ASX, Brazilian Rare Earths, Liontown, and Sigma shares are sinking today

    These shares are under pressure on Thursday. But why?

    Read more »

    A female scientist sits at her desk looking stressed out while working in an AnteoTech lab.
    Healthcare Shares

    Sigma share price dives 6% on Chemist Warehouse merger hurdle

    The proposed merger faces ACCC concerns.

    Read more »

    The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was another horrid day for ASX investors this hump day.

    Read more »

    Woman looks amazed and shocked as she looks at her laptop.
    Share Gainers

    Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

    These shares are having a good session on hump day. But why?

    Read more »

    A young woman wearing a blue and white striped t-shirt blows air from her cheeks and looks up and to the side in a sign of disappointment after the ASX shares she owns went down today
    Share Market News

    Why Arafura, Pentanet, Sigma, and Webjet shares are falling today

    These shares are ending the week in the red. But why?

    Read more »

    a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
    Share Gainers

    Why Australian Strategic Metals, Evolution, Sigma, and Webjet shares are storming higher

    These ASX shares are having a very strong session. But why>

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Earnings Results

    Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

    This could be the last set of results from Sigma as we know it if its merger is approved.

    Read more »

    A player pounces on the ball in the scoring zone of the field.
    Investing Strategies

    'Start building a position': 3 ASX shares to pounce on right now

    Inflation and interest rates might be on everyone's minds this week, but experts reckon this trio is looking good no…

    Read more »

    Scientists working in the laboratory and examining results.
    Share Market News

    2 ASX healthcare shares with 'significant growth opportunities'

    This fund manager has named revealed some healthy opportunities.

    Read more »

    A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
    Share Fallers

    Why Azure Minerals, Brainchip, Core Lithium, and Sigma shares are falling

    These ASX shares are starting the week in the red.

    Read more »

    A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
    Share Fallers

    Why Australian Clinical Labs, Meridian, MyState, and Sigma shares are falling today

    These ASX shares are ending the week in the red. But why?

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why BlueScope, Fortescue, Polynovo, and Sigma shares are racing higher

    These ASX shares are having a strong session on hump day. But why?

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jun 2024 $1.16 $-0.05 -4.15% 37,821,710 $1.10 $1.16 $1.08
    12 Jun 2024 $1.21 $0.03 2.54% 7,194,239 $1.19 $1.22 $1.18
    11 Jun 2024 $1.18 $0.00 0.00% 8,284,103 $1.15 $1.19 $1.15
    07 Jun 2024 $1.18 $0.00 0.00% 8,828,668 $1.18 $1.18 $1.15
    06 Jun 2024 $1.18 $-0.03 -2.49% 9,050,626 $1.20 $1.21 $1.16
    05 Jun 2024 $1.21 $0.01 0.83% 4,558,612 $1.20 $1.21 $1.18
    04 Jun 2024 $1.20 $-0.01 -0.83% 6,224,882 $1.21 $1.22 $1.18
    03 Jun 2024 $1.21 $-0.04 -3.19% 6,003,241 $1.27 $1.27 $1.21
    31 May 2024 $1.26 $0.01 0.81% 13,080,864 $1.25 $1.28 $1.25
    30 May 2024 $1.24 $0.00 0.00% 4,602,037 $1.24 $1.25 $1.23
    29 May 2024 $1.24 $-0.01 -0.80% 6,757,976 $1.24 $1.26 $1.22
    28 May 2024 $1.25 $0.01 0.81% 2,623,588 $1.24 $1.26 $1.23
    27 May 2024 $1.24 $0.02 1.64% 6,180,106 $1.23 $1.26 $1.22
    24 May 2024 $1.22 $0.00 0.00% 5,023,584 $1.20 $1.22 $1.20
    23 May 2024 $1.22 $-0.03 -2.40% 5,462,859 $1.24 $1.24 $1.22
    22 May 2024 $1.25 $0.00 0.00% 2,989,143 $1.26 $1.27 $1.25
    21 May 2024 $1.25 $0.01 0.81% 5,311,322 $1.25 $1.26 $1.24
    20 May 2024 $1.24 $0.00 0.00% 5,731,562 $1.24 $1.25 $1.23
    17 May 2024 $1.24 $-0.02 -1.59% 3,584,621 $1.26 $1.26 $1.24
    16 May 2024 $1.26 $0.01 0.80% 4,535,684 $1.26 $1.28 $1.26
    15 May 2024 $1.25 $0.01 0.81% 4,595,358 $1.24 $1.26 $1.23

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Apr 2024 Christopher Roberts Buy 3,657 $4,461
    Directors' share plan.
    08 Apr 2024 Neville Mitchell Buy 4,334 $5,286
    Directors' share plan.
    08 Apr 2024 Kathryn (Kate) Spargo Buy 4,740 $5,782
    Directors' share plan.
    08 Apr 2024 Michael Sammells Buy 7,855 $9,582
    Directors' share plan.
    08 Apr 2024 Annette Carey Buy 3,656 $4,459
    Directors' share plan.
    29 Jan 2024 Michael Sammells Issued 81,444 $57,010
    Rights issue.
    29 Jan 2024 Annette Carey Issued 3,708 $2,595
    Rights issue.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 129,730 $90,811
    Rights issue.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 111,548 $78,083
    Rights issue.
    29 Jan 2024 Neville Mitchell Issued 6,474 $4,531
    Rights issue.
    10 Jan 2024 Kathryn (Kate) Spargo Buy 5,442 $5,169
    Directors' share plan.
    10 Jan 2024 Christopher Roberts Buy 4,696 $4,460
    Directors' share plan.
    10 Jan 2024 Neville Mitchell Buy 5,566 $5,286
    Directors' share plan.
    10 Jan 2024 Annette Carey Buy 4,697 $4,461
    Directors' share plan.
    10 Jan 2024 Michael Sammells Buy 10,612 $10,079
    Directors' share plan.
    20 Dec 2023 Vikesh Ramsunder Exercise 1,482,423 $1,467,598
    Conversion of securities. 48,35,167 Rights
    20 Dec 2023 Vikesh Ramsunder Issued 1,482,423 $1,467,598
    Conversion of securities.
    10 Jul 2023 Annette Carey Buy 5,489 $4,460
    Directors' share plan.
    10 Jul 2023 Christine Bartlett Buy 6,506 $5,286
    Directors' share plan.
    10 Jul 2023 Michael Sammells Buy 11,792 $9,582
    Directors' share plan.
    10 Jul 2023 Neville Mitchell Buy 5,490 $4,461
    Directors' share plan.
    10 Jul 2023 Kathryn (Kate) Spargo Buy 7,116 $5,782
    Directors' share plan.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts has more than 40 years' experience in the medical device industry, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He Held Directorship in Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell has financial experience coupled with experience as an active Non-Executive Director. Mr Mitchell is a current Director and Chair of the Audit Committee of Sonic Healthcare. Mr Mitchell is also a Non-Executive Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Mr Mitchell is a qualified Chartered Accountant with international healthcare and finance experience. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.
    Ms Kathryn (Kate) Dianne Spargo Non-Executive Director Dec 2015
    Ms Spargo has gained business experience as an advisor, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently a Non-Executive Director at the following listed entities is Sonic Healthcare Limited, Adairs Limited and Bapcor Ltd. In addition Ms Spargo is also currently a Non-Executive Director at CIMIC Ltd (now unlisted). Over the last three years, Ms Spargo was a Non-Executive Director at Xenith IP Ltd. In September 2021, Ms Spargo retired from her position as Chairman of CoInvest and at the same time joined the board of the unlisted company Jellis Craig. Ms Spargo is also Director at the Geelong Football Club and Future Fuels Cooperative Research Centre.
    Mr Michael Sammells Non-Executive DirectorInterim Chairman Feb 2020
    Mr Sammells has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a current Director of GMHBA Limited and is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder has culmination of a 28 year career with the Clicks Group which included 18 years as part of the executive team. Before becoming Clicks CEO Vikesh held a number of roles within the Group, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is a current Director of National Intermodal Corporation, a Non-Executive Director of Flinders Port Holdings Pty Ltd, a Non-Executive Director of Kinetic, and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global. Ms Carey brings a balance of technical expertise as well as legal, strategic, and commercial intellect from over 20 years' experience in supply chain, logistics and cross border ecommerce. Ms Carey has previously held various senior roles within the Linfox Logistics group progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
    Ms Kara McGowan General CounselCompany Secretary Oct 2021
    -
    Kara McGowan General CounselCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hmc Capital Partners Holdings Pty Ltd 311,242,135 19.07%
    Hsbc Custody Nominees (Australia) Limited 295,751,528 18.12%
    Citicorp Nominees Pty Limited 248,058,343 15.20%
    J P Morgan Nominees Australia Pty Limited 164,445,049 10.08%
    National Nominees Limited 64,967,710 3.98%
    Sigma Employee Share Admin P/L 37,184,497 2.28%
    Pacific Custodians Pty Limited 32,103,793 1.97%
    Ubs Nominees Pty Ltd 27,854,014 1.71%
    Bnp Paribas Nominees Pty Ltd 12,983,279 0.80%
    Hsbc Custody Nominees (Australia) Limited II 11,673,531 0.72%
    Bnp Paribas Noms Pty Ltd 11,172,115 0.68%
    Invia Custodian Pty Limited 7,596,481 0.47%
    Hsbc Custody Nominees (Australia) Limited A/C 2 7,365,783 0.45%
    Warbont Nominees Pty Ltd 5,805,877 0.36%
    Lygon Finance Pty Ltd 4,906,459 0.30%
    Citicorp Nominees Pty Limited II 4,794,059 0.29%
    Merrill Lynch (Australia) Nominees Pty Limited 4,281,681 0.26%
    Bnpp Noms Pty Ltd Hub24 Custodial Serv Ltd 4,049,515 0.25%
    Bnp Paribas Nominees Pty Ltd Barclays 3,406,856 0.21%
    Netwealth Investments Limited 3,315,488 0.20%

    Profile

    since

    Note